Asmanex Twisthaler Articles
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
Bayer: ICAM-1 news
25 September 1995
Sandoz' Calcitonin Spray Approved
11 September 1995
US OK For Miacalcin
4 September 1995
Glaxo Wellcome Takes Hanson's Bonham On Board
10 July 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
Euro Osteoporosis Market Fuelled By HRT And Aging
12 June 1995
Sandoz Receives Recommended Approval In USA
6 March 1995
Merck's Alendronate: Filing In USA Soon?
27 February 1995
Flonase Launch In USA
19 December 1994
Calcitonin Nasal Spray Set For US Approval?
28 November 1994
McNeil To Market Nicotine Nasal Spray
21 November 1994
Glaxo Receives Approval For Flonase
31 October 1994
ASTA Medical Launch In France
24 October 1994
FDA Considers Nicotine Nasal Spray
22 August 1994
Cephalon Starts Phase III Modafinil Trials
15 August 1994
Felbatol Approval Marks Year At Carter-Wallace
1 August 1994
DESMOPRESSIN NASAL SPRAY
9 May 1994
UNCERTAINTY OVER SWEDISH OTC PLANS
9 May 1994
NASAL SPRAY FOR RSV INFECTION TESTED
21 February 1994
OTC BECONASE TO BECOME AVAILABLE
14 February 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
AVIRON WORKING ON NASAL FLU VACCINE
13 December 1993
NEW UK LIMITED LIST DETAILS ANNOUNCED
25 October 1993
UK TO DELIST 62 MORE MEDICINES FROM NHS
23 August 1993
DURA ABANDONS PENTYDE
9 August 1993
ROUND UP OF PRODUCT SWITCHES
12 July 1993
GLAXO DRUG MAY OFFER FLU THERAPY
7 June 1993
LONG-TERM CALCITONIN MAINTAINS BONE MASS
19 April 1993
JOUVEINAL PRODUCTS EFFECT ON W-L PIPELINE
8 February 1993
EURO OSTEOPOROSIS MARKET TO BOOM?
14 December 1992
NASAL ASPIRIN
25 May 1992
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
